Standard Biotools Inc (LAB)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $279.27M
Last updated: Nov 17, 2026 at 11:02 AM ET
Standard Biotools Inc (LAB) Stock Forecast
Analysts expect Standard Biotools (LAB) to earn -$0.10 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.16.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$0.10
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.16
- EPS consensus, revenue $82.10M
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.10 | -$0.10 to -$0.10 | 1 | N/A | N/A | 0 |
| Dec 31, 2027 | -$0.16 | -$0.16 to -$0.16 | 1 | $82.10M | $82.10M to $82.10M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.02 | -$0.02 to -$0.02 | 2 | $21.21M | $20.58M to $22.05M | 2 |
Estimate Revisions
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.16.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.10 | -$0.16 | -$0.16 | -$0.16 | -$0.16 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.16 | -$0.14 | -$0.13 | -$0.15 | -$0.14 | N/A |
Frequently Asked Questions About LAB
What is the LAB stock forecast?
Consensus analyst estimates put Standard Biotools's EPS at -$0.10 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from LAB next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.10, with estimates from -$0.10 to -$0.10 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.16, with estimates from -$0.16 to -$0.16 from 1 analyst.
What revenue do analysts expect from Standard Biotools next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $82.10M, with estimates from $82.10M to $82.10M.
How many analysts cover LAB?
1 analyst estimates EPS for Standard Biotools for the fiscal year ending Dec 31, 2026.
LAB pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts